Clinical Trials List
2025-06-01 - 2029-12-31
Phase IV
Recruiting4
ICD-10C83.00
Small cell B-cell lymphoma, unspecified site
ICD-10C83.09
Small cell B-cell lymphoma, extranodal and solid organ sites
ICD-10C83.80
Other non-follicular lymphoma, unspecified site
ICD-10C83.89
Other non-follicular lymphoma, extranodal and solid organ sites
ICD-10C83.90
Non-follicular (diffuse) lymphoma, unspecified, unspecified site
ICD-10C83.99
Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites
ICD-10C86.5
Angioimmunoblastic T-cell lymphoma
ICD-10C86.6
Primary cutaneous CD30-positive T-cell proliferations
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9200.80
Other named variants lymphoma, unspecified site, extranodal solid organ sites
-
Trial Applicant
TTY Biopharm Company Limited
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
50 participants
